4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-enol, 95.0%, 10g

4-[1-(4-fluorophenyl)-1H-tetrazol-5-yl]piperidine, 250mg

N-(3-Aminopropyl)carbamic acid tert-butyl ester, 96.0%, 100g

3-{[1,1'-biphenyl]-4-yl}-5-methyl-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 2g

2-Ethylpyrrole, 99.0%, 5g

5-Norbornene-2-carboxylic Acid (endo- and exo- mixture)>98.0%(GC)(T)25g

1,1,1,2,2-Pentafluoro-4-iodobutane>98.0%(GC)5g

tert-Butyldimethyl((2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)oxy)silane, 97%, 5g

D-Luciferin, 95%, 100mg

(2R,4S)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride, 98%, 250mg

(2E)-1-(2-chlorophenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 2g

ethyl 5-(3,4-dimethoxyphenyl)-5-oxovalerate, 97.0%, 1g

Copper(I) Bromide>98.0%(T)100g